|
US4543359A
|
|
Treating cardiac arrhythmias with dantrolene sodium
|
|
US4370313A
|
|
Nitrofurantoin dosage form
|
|
US2652402A
|
|
Series of new-3-amino-2-oxazolidones and the preparation thereof
|
|
US2660607A
|
|
Process of making 2-hydroxyethylhydrazine
|
|
GB698271A
|
|
Improvements in or relating to process of making 5-nitro-2-furaldehyde thiosemicarbazone
|
|
US2599509A
|
|
5-nitro-2-furfurylidene acetone semicarbazone
|
|
US2626258A
|
|
Series of nitrofuran compounds comprising the acyl hydrazone ammonium salts of 5-nitroacyl furans
|
|
US2663710A
|
|
Series of nitrofuran compounds comprising 5-nitro-2-furyl 2-dialkyl-aminoalkyl ketone semicarbazone salts
|
|
US2656350A
|
|
Series of nitrofuran compounds comprising substituted 5-nitro-2-furaldehyde semicarbazones
|
|
US2610181A
|
|
Series of nitrofuran compounds comprising the azomethines of 5-nitro-2-acyl furans with 1-amino-hydantoins
|
|
GB679202A
|
|
Improvements in or relating to the production of 5-nitrofuran derivatives
|
|
GB649027A
|
|
Improvements in or relating to production of 5-nitro-2-furaldehyde semi-carbazone
|
|
US2416238A
|
|
5-nitro-2-furaldehyde semioxamazone
|
|
US2416239A
|
|
5-nitro-2-furaldehyde thiosemicarbazone
|
|
US2416237A
|
|
5-nitro-2-furaldehyde 5' (beta-hydroxyethyl) semioxamazone
|
|
US2416236A
|
|
Series of nitrofuran compounds
|
|
US2490006A
|
|
Process of nitrating furan derivatives
|
|
US2548173A
|
|
Process of making 5-nitro-2-furaldehyde semicarbazone
|
|
GB627845A
|
|
Improvements in or relating to compositions for use in surgical dressings
|
|
US2436184A
|
|
Pharmaceutical jelly
|
